Brief: Maxcyte Announces Operational Restructuring To Reduce Costs
Sept 22 (Reuters) - MaxCyte Inc MXCT.O: MAXCYTE ANNOUNCES OPERATIONAL RESTRUCTURING TO REDUCE COSTS AND ACCELERATE PATH TO PROFITABILITY MAXCYTE INC - TO REDUCE 34% OF GLOBAL WORKFORCE MAXCYTE INC - EXPECTS $13.6 MILLION IN ANNUALIZED SAVINGS FROM RESTRUCTURING MAXCYTE INC - EXPECTS 2025 CORE REVENUE FLAT TO DOWN 10% Source text: ID:nGNXCq9Kk Further company coverage: MXCT.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on MaxCyte
See all newsCell-engineering firm MaxCyte's Q3 revenue beats; annual outlook lifted
Brief: MaxCyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
MaxCyte Inc reports results for the quarter ended June 30 - Earnings Summary
MaxCyte Q2 revenue beats estimates
MaxCyte Inc expected to post a loss of 9 cents a share - Earnings Preview